Leica Biosystems Unveils Novel Fluorescent Digital Pathology Scanner, the Aperio FL Digital System, at AACR Annual Meeting
VISTA, California, April 25, 2025 – Leica Biosystems is pleased to announce the debut of its latest digital pathology innovation, the Aperio FL digital system, at the American Association of Cancer Researchers (AACR) Annual Meeting in Chicago, Illinois, from April 25-30, 2025.
The Aperio FL digital system, featuring the FL 10 or FL 120 scanner, is redefining digital pathology through its multi-modal Whole Slide Image (WSI) scanning capabilities. Seamlessly integrating brightfield, fluorescent, and FISH applications with high magnification oil scanning, this advanced platform delivers exceptional image quality and remarkable detail. Its cutting-edge technology ensures optimal resolution, empowering researchers with the clarity needed for the thorough investigation of every slide.
Leica Biosystems has a legacy of over 25 years of innovation, boasting more than 380 image capture technology patents and world-renowned Leica optics.
“We are thrilled to unveil the Aperio FL digital system to the global research community,” said Naveen Chandra, Vice President and General Manager of Digital Pathology at Leica Biosystems. “Leading institutions, such as Sarepta Therapeutics in Cambridge, Massachusetts, and Medical Park Hospital in Istanbul, Turkey, have been among the first to evaluate the system. Their insights have been overwhelmingly positive, emphasizing the system’s outstanding performance, robust stability, and intuitive user experience across both hardware and software.”
The Aperio FL digital system is set to become an invaluable tool for researchers, enhancing the accuracy and efficiency of pathological investigations. Attendees of the AACR Annual Meeting are invited to visit booth #3108 for a live, educational, and hands-on experience. For more information, please visit Aperio FL scanners.
About Leica Biosystems
Leica Biosystems is a global leader in workflow solutions and automation, providing anatomic pathology laboratories with the most comprehensive product portfolio and easy-to-use solutions. With a commitment to advancing cancer diagnostics, Leica Biosystems continues to drive innovation and improve patient outcomes.
SOURCE: Leica Biosystems
